Angioedema - 88 Studies Found
| Recruiting |
: Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients : Hereditary Angioedema : 2011-05-19 : Drug: rhC1INH Patients up to 84 kg will receive one i.v. injection of Ruconest at a dose of 50 U/kg. The |
| Terminated |
: Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema : ACE Inhibitor-associated Angioedema : 2011-12-14 :
|
| Completed |
: Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks : Hereditary Angioedema : 2012-06-29 : Biological: CINRYZE with rHuPH20 Other Names:
|
| Completed |
: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-07-29 :
|
| Completed |
: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-04-04 : Drug: ecallantide solution for SC injection, one 30 mg dose per HAE attack |
| Completed |
: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) : Hereditary Angioedema : 2009-06-02 :
|
| Completed |
: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-07-12 :
|
| Withdrawn |
: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema : Hereditary Angioedema : 2010-12-02 : Biological: ecallantide 10 - 30mg subcutaneous injection. |
| Completed |
: CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 : Hereditary Angioedema : 2010-03-24 : Biological: CINRYZE Other Name: C1 inhibitor [human] |
| Completed |
: Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects : Hereditary Angioedema : 2014-03-17 :
|